For Giles Turner's latest contributions to The Japan Times, see below:
The company is adjusting plans for an initial public offering of its chip technology division and will likely still list the majority of what it offers for trading on U.S. exchanges.
The adoption of prudence at SoftBank’s Vision Fund is an about-face from its past freewheeling largess.
Marcelo Claure, who was SoftBank’s second-highest paid executive in the latest financial year, has often pushed for much more money and authority, putting him at odds with Masayoshi Son.
The purchase — poised to become the biggest chip deal ever when it was announced in 2020 — has drawn a fierce backlash from regulators and the chip industry.
THG became a billion-dollar company through makeup and supplements that were wildly popular on social media. The good times didn’t last.
Ampere is a 4-year-old startup run by a former Intel Corp. executive who is trying to break into the market for microprocessors that run servers in data centers, an area dominated by her old company.
Roche's diagnostics unit reacted swiftly to the pandemic, and now sales are boosted by its COVID-19 testing business.
Nvidia, the biggest U.S. chip company by market capitalization, announced in September a $40 billion deal to acquire Arm from Japan’s SoftBank Group.
Greensill Capital was a key part of what Son dubbed his "Cluster of No. 1’s” strategy, taking noncontrolling stakes in the world’s leading tech companies and encouraging them to cooperate.
Under Japanese regulations, founder Masayoshi Son could compel other shareholders to sell when he gets to 66% ownership, perhaps without paying a premium.
